Concepedia

T. Crosby

TC

32

Publications

2K

Citations

21

H-Index

1997

Active since

Affiliations

Velindre Cancer Centre(Current)

Cardiff University

University of Oxford

Velindre NHS Trust

Royal Surrey County Hospital

T. Crosby is an author at Velindre Cancer Centre specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1997–2023

32

Publications

32

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

T. Crosby, Stephen Falk, Simon Gollins et al. · The Lancet Oncology · 2013 · 378 citations · Full text

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

David Cunningham, Sally Stenning, Elizabeth Smyth et al. · The Lancet Oncology · 2017 · 282 citations · Full text

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Brian O’Neill, S M Griffin, C. Mariette et al. · BMC Cancer · 2017 · 156 citations · Full text

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 155 citations · Full text

Neo-AEGIS (Neoadjuvant trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study): Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy (Modified MAGIC or FLOT protocol). (NCT01726452).

John V. Reynolds, Shaun R. Preston, Brian O’Neill et al. · Journal of Clinical Oncology · 2021 · 113 citations

, , +19

Rows per page

1–5 of 32